The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group
Acta Diabetologica · 2025
DOI: 10.1007/s00592-025-02592-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Diabetologica, 2025. Verfasst von Veronica Resi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy. veronica.resi@policlinico.mi.it. Hauptthemen laut MEDLINE: Pregnancy in Diabetics, Diabetes, Gestational, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Over the last 10 years, the number of women with diabetes during pregnancy has increased steadily. Maternal glycaemic control is the most important factor influencing maternal and neonatal outcomes, and technological advances have become integral to the evolution of diabetes care during pregnancy. However, rapid technological development must be accompanied by the equally rapid dissemination of information. In particular, knowledge of the availability of automated insulin delivery (AID) systems for managing type 1 diabetes in pregnancy, and of glucose continuous monitoring (CGM) systems for gestational and type 2 diabetes, needs to be increased. The AMD-SID Italian Diabetes and Pregnancy Study Group, supported by the Technology and Diabetes Study Group, has produced this position paper of expert opinion to review the main international guidelines and current evidence on new technologies for the management of pregnancy in women with GDM, type 1 and type 2 diabetes, and to provide detailed suggestions for the use of commercially available systems in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy. veronica.resi@policlinico.mi.it.
- Section of Diabetes and Metabolic Diseases, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Diabetes and Endocrinology Unit, ULSS8 Berica, Arzignano, Veneto, VI, Italy.
- Endocrinology Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy.
- Diabetes Unit, AUSL Reggio Emilia, Reggio Emilia, Italy.
- Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Zitieren
APA
Resi, V., Bianchi, C., Burlina, S., Grancini, V., Manicardi, E., Masulli, M., Scarpitta, A. M., Sorice, G. P., & Fresa, R. (2025). The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group. Acta Diabetologica. https://doi.org/10.1007/s00592-025-02592-2
Vancouver
Resi V, Bianchi C, Burlina S, Grancini V, Manicardi E, Masulli M, et al. The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group. Acta Diabetologica. 2025. doi:10.1007/s00592-025-02592-2
BibTeX
@article{Resi2025,
author = {Resi, Veronica and Bianchi, Cristina and Burlina, Silvia and Grancini, Valeria and Manicardi, Elisa and Masulli, Maria and Scarpitta, Antonietta Maria and Sorice, Gian Pio and Fresa, Raffaella},
title = {The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group},
journal = {Acta Diabetologica},
year = {2025},
doi = {10.1007/s00592-025-02592-2}
}
EUVIMED